These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
618 related articles for article (PubMed ID: 19108994)
1. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. De Clercq E Int J Antimicrob Agents; 2009 Apr; 33(4):307-20. PubMed ID: 19108994 [TBL] [Abstract][Full Text] [Related]
2. The history of antiretrovirals: key discoveries over the past 25 years. De Clercq E Rev Med Virol; 2009 Sep; 19(5):287-99. PubMed ID: 19714702 [TBL] [Abstract][Full Text] [Related]
3. Anti-HIV drugs. De Clercq E Verh K Acad Geneeskd Belg; 2007; 69(2):81-104. PubMed ID: 17550060 [TBL] [Abstract][Full Text] [Related]
4. New anti-HIV agents and targets. De Clercq E Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088 [TBL] [Abstract][Full Text] [Related]
5. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations. Pinheiro Edos S; Antunes OA; Fortunak JM Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral drugs. De Clercq E Curr Opin Pharmacol; 2010 Oct; 10(5):507-15. PubMed ID: 20471318 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537 [TBL] [Abstract][Full Text] [Related]
9. AIDS in the Third World: how to stop the HIV infection? De Clercq E Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics of antiretroviral drugs]. Ribera E; Tuset M; MartÃn M; del Cacho E Enferm Infecc Microbiol Clin; 2011 May; 29(5):362-91. PubMed ID: 21531048 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography. Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Storch CH; Theile D; Lindenmaier H; Haefeli WE; Weiss J Biochem Pharmacol; 2007 May; 73(10):1573-81. PubMed ID: 17328866 [TBL] [Abstract][Full Text] [Related]
13. New developments in anti-HIV chemotherapy. De Clercq E Biochim Biophys Acta; 2002 Jul; 1587(2-3):258-75. PubMed ID: 12084468 [TBL] [Abstract][Full Text] [Related]
15. New developments in anti-HIV chemotherapy. De Clercq E Curr Med Chem; 2001 Nov; 8(13):1543-72. PubMed ID: 11562282 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Else LJ; Taylor S; Back DJ; Khoo SH Antivir Ther; 2011; 16(8):1149-67. PubMed ID: 22155899 [TBL] [Abstract][Full Text] [Related]
17. Drugs for HIV infection. Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928 [No Abstract] [Full Text] [Related]
18. [AIDS; new developments. II. Treatment of HIV infection]. Borleffs JC; Esseveld F; Hoepelman IM; Boucher CA Ned Tijdschr Geneeskd; 1997 May; 141(21):1036-43. PubMed ID: 9340560 [TBL] [Abstract][Full Text] [Related]
20. HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches. De Clercq E Int J Biochem Cell Biol; 2004 Sep; 36(9):1800-22. PubMed ID: 15183346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]